000 01464 a2200421 4500
005 20250513035050.0
264 0 _c19950920
008 199509s 0 0 eng d
022 _a0006-2952
024 7 _a10.1016/0006-2952(95)00157-u
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMarks, D C
245 0 0 _aExpression of multidrug resistance in response to differentiation in the K562 human leukaemia cell line.
_h[electronic resource]
260 _bBiochemical pharmacology
_cAug 1995
300 _a475-80 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aATP Binding Cassette Transporter, Subfamily B, Member 1
_xanalysis
650 0 4 _aButyrates
_xpharmacology
650 0 4 _aButyric Acid
650 0 4 _aCell Differentiation
650 0 4 _aCell Survival
650 0 4 _aColchicine
_xpharmacology
650 0 4 _aDrug Resistance, Multiple
650 0 4 _aEpirubicin
_xpharmacology
650 0 4 _aHumans
650 0 4 _aLeukemia
_xdrug therapy
650 0 4 _aPhenotype
650 0 4 _aRhodamine 123
650 0 4 _aRhodamines
650 0 4 _aTetradecanoylphorbol Acetate
_xpharmacology
650 0 4 _aTumor Cells, Cultured
_xdrug effects
650 0 4 _aVerapamil
_xpharmacology
700 1 _aDavey, M W
700 1 _aDavey, R A
700 1 _aKidman, A D
773 0 _tBiochemical pharmacology
_gvol. 50
_gno. 4
_gp. 475-80
856 4 0 _uhttps://doi.org/10.1016/0006-2952(95)00157-u
_zAvailable from publisher's website
999 _c7645983
_d7645983